An Optimized Triple Modality Reporter for Quantitative In Vivo Tumor Imaging and Therapy Evaluation

We present an optimized triple modality reporter construct combining a far-red fluorescent protein (E2-Crimson), enhanced firefly luciferase enzyme (Luc2), and truncated wild type herpes simplex virus I thymidine kinase (wttk) that allows for sensitive, long-term tracking of tumor growth in vivo by...

Descripción completa

Detalles Bibliográficos
Autores principales: Levin, Rachel A., Felsen, Csilla N., Yang, Jin, Lin, John Y., Whitney, Michael A., Nguyen, Quyen T., Tsien, Roger Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016317/
https://www.ncbi.nlm.nih.gov/pubmed/24816650
http://dx.doi.org/10.1371/journal.pone.0097415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016317/
https://www.ncbi.nlm.nih.gov/pubmed/24816650
http://dx.doi.org/10.1371/journal.pone.0097415

Ejemplares similares